IMMUNITYBIO, INC. Operating Lease, Payments
IMMUNITYBIO, INC. (IBRX) reported Operating Lease, Payments of $6.31 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-04
- IMMUNITYBIO, INC. operating lease, payments for the quarter ending 2026-06-30 was $3.13M, a 6.93% increase year-over-year.
- IMMUNITYBIO, INC. operating lease, payments for the quarter ending 2026-03-31 was $3.18M, a 8.68% increase year-over-year.
- IMMUNITYBIO, INC. operating lease, payments for the quarter ending 2025-12-31 was $2.91M, a 4.87% increase year-over-year.
- IMMUNITYBIO, INC. operating lease, payments for the quarter ending 2025-09-30 was $2.91M, a 2.11% increase year-over-year.
- IMMUNITYBIO, INC. operating lease, payments for fiscal 2025 was $11.67M, a 9.66% increase from fiscal 2024.
- IMMUNITYBIO, INC. operating lease, payments for fiscal 2024 was $10.64M, a 11.57% increase from fiscal 2023.
- IMMUNITYBIO, INC. operating lease, payments for fiscal 2023 was $9.54M, a 6.86% decline from fiscal 2022.
- IMMUNITYBIO, INC. operating lease, payments for fiscal 2022 was $10.24M, a 13.36% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $6.31M 10-Q · filed 2026-08-04 | $9.22M derived: sum of 3 quarters · filed 2026-08-04 | $12.13M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $3.18M 10-Q · filed 2026-05-07 | $6.09M derived: sum of 2 quarters · filed 2026-05-07 | $8.99M derived: sum of 3 quarters · filed 2026-05-07 | $11.92M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $5.82M derived: sum of 2 quarters · filed 2026-02-23 | $8.74M derived: sum of 3 quarters · filed 2026-08-04 | $11.67M 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | $2.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.84M derived: sum of 2 quarters · filed 2026-08-04 | $8.76M 10-Q · filed 2025-11-05 | $11.54M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $2.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $5.86M 10-Q · filed 2026-08-04 | $8.63M derived: sum of 3 quarters · filed 2026-08-04 | $11.47M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $2.92M 10-Q · filed 2026-05-07 | $5.70M derived: sum of 2 quarters · filed 2026-05-07 | $8.54M derived: sum of 3 quarters · filed 2026-05-07 | $11.18M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $5.62M derived: sum of 2 quarters · filed 2026-02-23 | $8.26M derived: sum of 3 quarters · filed 2026-02-23 | $10.64M 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | $2.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.48M derived: sum of 2 quarters · filed 2025-11-05 | $7.87M 10-Q · filed 2025-11-05 | $9.69M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | $2.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $5.02M 10-Q · filed 2025-08-05 | $6.85M derived: sum of 3 quarters · filed 2026-02-23 | $8.72M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | $2.38M 10-Q · filed 2025-05-12 | $4.21M derived: sum of 2 quarters · filed 2026-02-23 | $6.08M derived: sum of 3 quarters · filed 2026-02-23 | $8.74M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $3.70M derived: sum of 2 quarters · filed 2026-02-23 | $6.36M derived: sum of 3 quarters · filed 2026-02-23 | $9.54M 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | $1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.53M derived: sum of 2 quarters · filed 2024-11-12 | $7.71M 10-Q · filed 2024-11-12 | $10.60M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $5.84M 10-Q · filed 2024-08-12 | $8.73M derived: sum of 3 quarters · filed 2025-03-03 | $10.99M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $3.18M 10-Q · filed 2024-05-09 | $6.07M derived: sum of 2 quarters · filed 2025-03-03 | $8.33M derived: sum of 3 quarters · filed 2025-03-03 | $11.27M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $5.15M derived: sum of 2 quarters · filed 2025-03-03 | $8.09M derived: sum of 3 quarters · filed 2025-03-03 | $10.24M 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.20M derived: sum of 2 quarters · filed 2023-11-09 | $7.35M 10-Q · filed 2023-11-09 | $10.51M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-06-30 | $2.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $5.09M 10-Q · filed 2023-08-08 | $8.25M derived: sum of 3 quarters · filed 2024-03-19 | $10.12M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-03-31 | $2.15M 10-Q · filed 2023-05-11 | $5.31M derived: sum of 2 quarters · filed 2024-03-19 | $7.18M derived: sum of 3 quarters · filed 2024-03-19 | $9.51M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2021-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $5.03M derived: sum of 2 quarters · filed 2024-03-19 | $7.36M derived: sum of 3 quarters · filed 2024-03-19 | $9.03M 10-K · filed 2024-03-19 | ||||
| 2021-09-30 | $1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $4.20M derived: sum of 2 quarters · filed 2022-11-09 | $5.88M 10-Q · filed 2022-11-09 | $9.50M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $4.00M 10-Q · filed 2022-08-08 | $7.63M derived: sum of 3 quarters · filed 2022-08-08 | $8.72M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $1.68M 10-Q · filed 2022-05-10 | $5.30M derived: sum of 2 quarters · filed 2022-05-10 | $6.40M derived: sum of 3 quarters · filed 2022-05-10 | $7.50M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $4.72M derived: sum of 2 quarters · filed 2022-03-01 | $5.82M derived: sum of 3 quarters · filed 2022-03-01 | $7.84M 10-K · filed 2022-03-01 | $5.34M 10-K · filed 2021-03-04 | |||
| 2020-09-30 | $1.10M 10-Q · filed 2020-11-09 | $2.20M derived: sum of 2 quarters · filed 2020-11-09 | $4.22M 10-Q · filed 2021-11-12 | $3.20M 10-Q · filed 2020-11-09 | $7.83M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $1.10M 10-Q · filed 2020-08-07 | $2.79M 10-Q · filed 2021-08-12 | $2.10M 10-Q · filed 2020-08-07 | $6.73M derived: sum of 3 quarters · filed 2022-03-01 | $7.73M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $1.35M 10-Q · filed 2021-05-14 | $1.00M 10-Q · filed 2020-05-11 | $5.63M derived: sum of 2 quarters · filed 2022-03-01 | $6.63M derived: sum of 3 quarters · filed 2022-03-01 | $7.63M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $5.27M derived: sum of 2 quarters · filed 2022-03-01 | $6.27M derived: sum of 3 quarters · filed 2022-03-01 | $7.57M 10-K · filed 2022-03-01 | $4.40M 10-K · filed 2020-03-25 | |||
| 2019-09-30 | $1.00M 10-Q · filed 2020-11-09 | $2.00M derived: sum of 2 quarters · filed 2020-11-09 | $3.30M 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | $1.00M 10-Q · filed 2020-08-07 | $2.30M 10-Q · filed 2020-08-07 | ||||||
| 2019-03-31 | $1.30M 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |